International Clinical Trial: Development and Validation of a Risk Prediction Model for Moyamoya Disease and Moyamoya Syndrome

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131350) titled 'Development and Validation of a Risk Prediction Model for Moyamoya Disease and Moyamoya Syndrome' on Sept. 1.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Beijing Tiantan Hospital, Capital Medical University

Condition: Moyamoya disease or moyamoya syndrome

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-09-01

Target Sample Size: Patients with moyamoya disease or moyamoya syndrome:3000;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=338698

Disclaimer: Curated by HT Syndication....